These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27246284)

  • 21. Current concepts in the management of diabetic nephropathy.
    Waanders F; Visser FW; Gans RO
    Neth J Med; 2013 Nov; 71(9):448-58. PubMed ID: 24218418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
    Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J
    Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing care for Canadians with diabetic nephropathy in 2015.
    Lloyd A; Komenda P
    Can J Diabetes; 2015 Jun; 39(3):221-8. PubMed ID: 25805325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreas transplantation for the prevention of diabetic nephropathy.
    Stegall MD; Larson TS; Kudva YC; Grande JP; Nyberg SL; Prieto M; Velosa JA; Rizza RA
    Mayo Clin Proc; 2000 Jan; 75(1):49-56. PubMed ID: 10630757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
    Björck S
    Scand J Urol Nephrol Suppl; 1990; 126():1-51. PubMed ID: 2194280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy.
    Parving HH
    J Hypertens Suppl; 1998 Jan; 16(1):S99-101. PubMed ID: 9534107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis and treatment of chronic kidney disease: a review of our recent basic and clinical data.
    Tomino Y
    Kidney Blood Press Res; 2014; 39(5):450-89. PubMed ID: 25501571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium-glucose cotransporter 2 inhibition in type 1 diabetes: simultaneous glucose lowering and renal protection?
    Cherney DZ; Perkins BA
    Can J Diabetes; 2014 Oct; 38(5):356-63. PubMed ID: 25192954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy.
    Sato A
    Hypertens Res; 2015 Jun; 38(6):367-74. PubMed ID: 25762415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic nephropathy for the primary care provider: new understandings on early detection and treatment.
    Kowalski A; Krikorian A; Lerma EV
    Ochsner J; 2014; 14(3):369-79. PubMed ID: 25249803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency.
    Li Vecchi M; Fuiano G; Francesco M; Mancuso D; Faga T; Sponton A; Provenzano R; Andreucci M; Tozzo C
    Nephron Clin Pract; 2007; 105(2):c62-7. PubMed ID: 17135770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between socioeconomic status and renal function in a population of German patients with diabetic nephropathy treated at a tertiary centre.
    Wolf G; Busch M; Müller N; Müller UA
    Nephrol Dial Transplant; 2011 Dec; 26(12):4017-23. PubMed ID: 21493815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New and old markers of progression of diabetic nephropathy.
    Jerums G; Premaratne E; Panagiotopoulos S; Clarke S; Power DA; MacIsaac RJ
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S30-7. PubMed ID: 18937992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of nephropathy in patients with type 2 diabetes.
    Critchley JA; Zhao HL; Tomlinson B; Leung W; Thomas GN; Chan JC; Cockram CS
    Chin Med J (Engl); 2002 Jan; 115(1):129-35. PubMed ID: 11930647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evidence-based review of ACE inhibitors in incipient diabetic nephropathy.
    Haider A; Oh P; Peloso PM
    Can J Clin Pharmacol; 2000; 7(2):115-9. PubMed ID: 10958708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The novella about diabetic nephropathy.
    Ivanac-Janković R; Lovčić V; Magaš S; Šklebar D; Kes P
    Acta Clin Croat; 2015 Mar; 54(1):83-91. PubMed ID: 26058248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.